Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.

McDonald, Kerrie Leanne; Khasraw, Mustafa; Ashley, David M

Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.

conference contribution

posted on 2022-11-25, 03:53 authored by Kerrie Leanne McDonald, Mustafa Khasraw, David M Ashley

Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.

History

Volume

33

Location

Chicago, IL

Start date

2015-05-29

End date

2015-06-02

ISSN

0732-183X

eISSN

1527-7755

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036900529&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Title of proceedings

JOURNAL OF CLINICAL ONCOLOGY

Event

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology

Identification of glioblastoma patients who stand to benefit from PARP inhibitor therapy.

History

Volume

Location

Start date

End date

ISSN

eISSN

Language

Author URL

Publication classification

Title of proceedings

Event

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports